5437-98-9COc1ccc(NC(=O)CC(C)=O)cc1SWAJJKROCOJICG-UHFFFAOYSA-N5437-98-9DTXSID7044689CHEMBL3185475Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 80.6% (104 of 129) of all reports.
Warning
H302 (18.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 129 reports by companies from 5 notifications to the ECHA C&L Inventory.
Chemical: Butanamide, N-(4-methoxyphenyl)-3-oxo-
REACH registered substance: 4'-methoxyacetoacetanilide (EC: 226-615-6)
UsesN-(4-Methoxyphenyl)-3-oxobutanamide is an intermediate in the synthesis of Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
No reaction records under the current filter.
Loading…